Based in Belgium, Animab is a startup. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Animab develops biotechnology-based solutions for animal health, focusing on preventing gastrointestinal infections in livestock through proprietary oral antibody technology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.